I-Flow Corporation

I-Flow Reports 21% Increase in Total Revenues for the Second Quarter of 2008 to $35.3 Million Versus $29.1 Million for the Second Quarter of 2007

Published in Hospital Law Weekly, August 21st, 2008

I-FLOW CORPORATION (NASDAQ:IFLO) announced that total revenue from continuing operations in the second quarter increased 21% to a record $35.3 million compared to $29.1 million for the same period of the prior year. Sales of Acute Care products, which include Regional Anesthesia (RA) sales of the Company's flagship ON-Q(R) product lines and AcryMed revenues, increased 21% for the second quarter of 2008 to $27.9 million compared to $23.0 million for the second quarter of 2007.

The loss from continuing operations before income taxes for this year's second quarter was $11.5 million. The $11.5 million loss amount included $12.2 million of certain litigation and insurance...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hospital Law Weekly

Source: Hospital Law Weekly (2008-08-21)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry